APA (7th ed.) Citation

C, X., WF, O., A, Q., J, T., BY, C., SWT, H., . . . P, T. (2020). HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer. Gut, 69(2), 231. https://doi.org/10.1136/gutjnl-2018-318025

Chicago Style (17th ed.) Citation

C, Xu, et al. "HNF4α Pathway Mapping Identifies Wild-type IDH1 as a Targetable Metabolic Node in Gastric Cancer." Gut 69, no. 2 (2020): 231. https://doi.org/10.1136/gutjnl-2018-318025.

MLA (9th ed.) Citation

C, Xu, et al. "HNF4α Pathway Mapping Identifies Wild-type IDH1 as a Targetable Metabolic Node in Gastric Cancer." Gut, vol. 69, no. 2, 2020, p. 231, https://doi.org/10.1136/gutjnl-2018-318025.